Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.
- DOI
- 10.1007/s00259-026-07834-1
- Published
- 2026 Jun
- Container
- European journal of nuclear medicine and molecular imaging
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-026-07834-1,
title = {Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.},
author = {Arnaldi D and Mattioli P and Orso B and Raffa S and Lanfranchi F and Massa F and Iranzo A and Perissinotti A and Niñerola-Baizán A and Gaig C and Serradell M and Montini A and Mayà G and Muñoz-Lopetegi A and Liguori C and Fernandes M and Placidi F and Chiaravalloti A and Šonka K and Dušek P and Zogala D and Trnka J and Boeve BF and Miyagawa T and Lowe VJ and Miyamoto T and Miyamoto M and Puligheddu M and Figorilli M and Serra A and Hu MT and Klein JC and Bes F and Kunz D and Cochen De Cock V and De Verbizier D and Plazzi G and Antelmi E and Pizza F and Terzaghi M and Bossert I and Kulcsárová K and Garibotto V and Nicastro N and Lathuilière A and Bonanni L and Morbelli S and Roascio M and Arnulfo G and Pardini M},
year = {2026},
journal = {European journal of nuclear medicine and molecular imaging},
doi = {10.1007/s00259-026-07834-1},
url = {https://doi.org/10.1007/s00259-026-07834-1}
}RIS
TY - JOUR TI - Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum. AU - Arnaldi D AU - Mattioli P AU - Orso B AU - Raffa S AU - Lanfranchi F AU - Massa F AU - Iranzo A AU - Perissinotti A AU - Niñerola-Baizán A AU - Gaig C AU - Serradell M AU - Montini A AU - Mayà G AU - Muñoz-Lopetegi A AU - Liguori C AU - Fernandes M AU - Placidi F AU - Chiaravalloti A AU - Šonka K AU - Dušek P AU - Zogala D AU - Trnka J AU - Boeve BF AU - Miyagawa T AU - Lowe VJ AU - Miyamoto T AU - Miyamoto M AU - Puligheddu M AU - Figorilli M AU - Serra A AU - Hu MT AU - Klein JC AU - Bes F AU - Kunz D AU - Cochen De Cock V AU - De Verbizier D AU - Plazzi G AU - Antelmi E AU - Pizza F AU - Terzaghi M AU - Bossert I AU - Kulcsárová K AU - Garibotto V AU - Nicastro N AU - Lathuilière A AU - Bonanni L AU - Morbelli S AU - Roascio M AU - Arnulfo G AU - Pardini M PY - 2026 JO - European journal of nuclear medicine and molecular imaging DO - 10.1007/s00259-026-07834-1 UR - https://doi.org/10.1007/s00259-026-07834-1 ER -
APA
D, A., P, M., B, O., S, R., F, L., F, M., A, I., A, P., A, N., C, G., M, S., A, M., G, M., A, M., C, L., M, F., F, P., A, C., K, Š., P, D., D, Z., J, T., BF, B., T, M., VJ, L., T, M., M, M., M, P., M, F., A, S., MT, H., JC, K., F, B., D, K., V, C. D. C., D, D. V., G, P., E, A., F, P., M, T., I, B., K, K., V, G., N, N., A, L., L, B., S, M., M, R., G, A., & M, P. (2026). Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-07834-1
Source records
- pubmed · retrieved 2026-09-26T09:16:13.957Z
- europe-pmc · retrieved 2026-09-26T09:16:13.971Z